Invention Grant
- Patent Title: Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B
-
Application No.: US17188819Application Date: 2021-03-01
-
Publication No.: US11643418B2Publication Date: 2023-05-09
- Inventor: Francis G. Fang , Dae-Shik Kim , Hyeong-Wook Choi , Charles E. Chase , Jaemoon Lee
- Applicant: EISAI R&D MANAGEMENT CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: EISAI R&D MANAGEMENT CO., LTD.
- Current Assignee: EISAI R&D MANAGEMENT CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Clark & Elbing LLP
- The original application number of the division: US16833923 2020.03.30
- Main IPC: C07D493/22
- IPC: C07D493/22 ; C07F7/18 ; C07D407/14 ; C07D307/28 ; C07D407/06 ; C07D493/14

Abstract:
The invention provides methods for the synthesis of eribulin or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate) through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Homer-Wadsworth-Emmons olefination), Dieckmann reaction, catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic intermediate. The invention also provides compounds useful as intermediates in the synthesis of eribulin or a pharmaceutically acceptable salt thereof and methods for preparing the same.
Public/Granted literature
Information query